LENZ Therapeutics (LENZ) Inventory (2020 - 2026)

LENZ Therapeutics (LENZ) has 6 years of Inventory data on file, last reported at $3.5 million in Q1 2026.

• On a quarterly basis, Inventory changed N/A year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $3.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.9 million, changed N/A from the prior year.
• Inventory for Q1 2026 stood at $3.5 million, up from $2.9 million in the prior quarter.
• Over the last five years, Inventory for LENZ reached as high as $3.5 million in Q1 2026 and fell as low as $39000.0 in Q2 2023.
• Historically, Inventory has averaged $2.0 million across 4 years, with a median of $2.1 million in 2023.
• Across the five-year window, Inventory surged 35.55% in 2022 and sank 97.68% in 2023, its largest moves.
• Year by year, Inventory stood at $2.5 million in 2022, then sank by 98.43% to $39000.0 in 2023, then soared by 7428.21% to $2.9 million in 2025, then climbed by 19.14% to $3.5 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $3.5 million in Q1 2026, $2.9 million in Q4 2025, and $949000.0 in Q3 2025.